News

Gabapentin, Valacyclovir Reduce Postherpetic Neuralgia in Herpes Zoster

Publish date: February 16, 2011

 

FROM THE ANNUAL MEETING OF THE AMERICAN ACADEMY OF DERMATOLOGY

Dr. Lapolla’s study was funded by the Foundation for Advances in Therapeutics and Prevention. The valacyclovir was provided by GlaxoSmithKline. Dr. Lapolla disclosed serving as a subinvestigator for NeurogesX and Inhibitex.

Pages

Recommended Reading

Pediatric Obesity Epidemic Means More Forearm Fractures
MDedge Internal Medicine
FDA Wants Lower Acetaminophen Doses in Prescription Pain Drugs
MDedge Internal Medicine
Big Gender Disparity Found in ACL Injury Risk
MDedge Internal Medicine
Data Support Use of Web-Based Non-Rx Therapies for Chronic Pain
MDedge Internal Medicine
FDA Clears iPhone/iPad App
MDedge Internal Medicine
Nonopioid Agents for Pain Management Being Studied
MDedge Internal Medicine
FDA Announces Voluntary Recall of Hydrocodone Bitartrate/Acetaminophen and Phenobarbital Products
MDedge Internal Medicine
What Should We Prescribe for Elderly Patients with Arthritis Pain?
MDedge Internal Medicine
Acute Ischemia in Raynaud's Needs Urgent Care
MDedge Internal Medicine
Gene Therapy Shows Promise for Treating Chronic Pain
MDedge Internal Medicine